The Moi University Clinical Research Centre (MUCRC) is located at AMPATH Centre, Moi Teaching and Referral Hospital, Eldoret. MUCRC was established by the Division of AIDS (DAIDS), National Institute of Allergy and Infectious Diseases (NIAID/NIH) of the United States’ DHHS to conduct clinical trials for the Adult AIDS Clinical Trials Group (AACTG).
MUCRC operates under the auspices of the USAID-AMPATH Partnership’s Research Network (AMPATH ResNet). AMPATH is a partnership between Moi University School of Medicine and Moi Teaching and Referral Hospital in Eldoret and a consortium of North American Medical Schools led by Indiana University School of Medicine. AMPATH has registered over 125,000 HIV-infected patients across 60 care and treatment sites in western Kenya. Roughly half of these patients have initiated antiretroviral therapy. Recently, AMPATH diversified its activities to include primary healthcare and chronic disease management. It is from the AMPATH patient pool that MUCRC recruits its study volunteers.
Since its inception in 2004, MUCRC has conducted several clinical trials funded by the ACTG. In 2009 MUCRC initiated non-DAIDS funded clinical research, notably commercial, industry sponsored protocols and research funded under EARNEST, a European research consortium.
The key EARNEST site personnel are Abraham Siika (PI), Kara K Wools-Kaloustian (Co-PI) and Priscilla C. Cheruiyot (Trial manager) and these are ably supported by a comprehensive and enthusiastic team including Charles Kwoba (Study Medical Officer), Simon Wachira (Study Pharmacist), Agnes Nzioka (Study Clinical Officer), Martha Mokaya (Study Data Manager) amongst others.